These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 32733206)
1. Connecting Immune Cell Infiltration to the Multitasking Microglia Response and TNF Receptor 2 Induction in the Multiple Sclerosis Brain. Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F; Agresti C Front Cell Neurosci; 2020; 14():190. PubMed ID: 32733206 [TBL] [Abstract][Full Text] [Related]
2. Neuronal injury in chronic CNS inflammation. Zindler E; Zipp F Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866 [TBL] [Abstract][Full Text] [Related]
3. Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis. Gao H; Danzi MC; Choi CS; Taherian M; Dalby-Hansen C; Ellman DG; Madsen PM; Bixby JL; Lemmon VP; Lambertsen KL; Brambilla R Cell Rep; 2017 Jan; 18(1):198-212. PubMed ID: 28052249 [TBL] [Abstract][Full Text] [Related]
4. Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis. Chomyk A; Kucinski R; Kim J; Christie E; Cyncynatus K; Gossman Z; Chen Z; Richardson B; Cameron M; Turner T; Dutta R; Trapp B Ann Neurol; 2024 May; 95(5):907-916. PubMed ID: 38345145 [TBL] [Abstract][Full Text] [Related]
5. TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease. Desu HL; Thougaard E; Carney BN; Illiano P; Plastini MJ; Florimon Y; Mini A; Guastucci C; Kang B; Lee JK; Lambertsen KL; Brambilla R Brain Behav Immun; 2025 Jan; 123():81-98. PubMed ID: 39243989 [TBL] [Abstract][Full Text] [Related]
6. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter. Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816 [TBL] [Abstract][Full Text] [Related]
7. Viscoelastic properties of white and gray matter-derived microglia differentiate upon treatment with lipopolysaccharide but not upon treatment with myelin. van Wageningen TA; Antonovaite N; Paardekam E; Brevé JJP; Iannuzzi D; van Dam AM J Neuroinflammation; 2021 Mar; 18(1):83. PubMed ID: 33781276 [TBL] [Abstract][Full Text] [Related]
8. Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis. Magliozzi R; Howell OW; Durrenberger P; Aricò E; James R; Cruciani C; Reeves C; Roncaroli F; Nicholas R; Reynolds R J Neuroinflammation; 2019 Dec; 16(1):259. PubMed ID: 31810488 [TBL] [Abstract][Full Text] [Related]
9. TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells. Desu HL; Illiano P; Choi JS; Ascona MC; Gao H; Lee JK; Brambilla R Cells; 2021 Jul; 10(7):. PubMed ID: 34359956 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation. Perga S; Montarolo F; Martire S; Bonaldo B; Bono G; Bertolo J; Magliozzi R; Bertolotto A Brain Pathol; 2021 Mar; 31(2):283-296. PubMed ID: 33051914 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis. Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F J Neuroinflammation; 2018 Jan; 15(1):18. PubMed ID: 29338732 [TBL] [Abstract][Full Text] [Related]
12. Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis. Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z Acta Neuropathol Commun; 2019 Apr; 7(1):58. PubMed ID: 31023379 [TBL] [Abstract][Full Text] [Related]
13. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment. van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283 [TBL] [Abstract][Full Text] [Related]
14. Molecular signature of slowly expanding lesions in progressive multiple sclerosis. Jäckle K; Zeis T; Schaeren-Wiemers N; Junker A; van der Meer F; Kramann N; Stadelmann C; Brück W Brain; 2020 Jul; 143(7):2073-2088. PubMed ID: 32577755 [TBL] [Abstract][Full Text] [Related]
15. Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis. Touil H; Li R; Zuroff L; Moore CS; Healy L; Cignarella F; Piccio L; Ludwin S; Prat A; Gommerman J; Bennett FC; Jacobs D; Benjamins JA; Lisak RP; Antel JP; Bar-Or A EBioMedicine; 2023 Oct; 96():104789. PubMed ID: 37703640 [TBL] [Abstract][Full Text] [Related]
16. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis. Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z Acta Neuropathol Commun; 2019 Dec; 7(1):205. PubMed ID: 31829262 [TBL] [Abstract][Full Text] [Related]
17. Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration. James RE; Schalks R; Browne E; Eleftheriadou I; Munoz CP; Mazarakis ND; Reynolds R Acta Neuropathol Commun; 2020 May; 8(1):66. PubMed ID: 32398070 [TBL] [Abstract][Full Text] [Related]
18. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats. Gardner C; Magliozzi R; Durrenberger PF; Howell OW; Rundle J; Reynolds R Brain; 2013 Dec; 136(Pt 12):3596-608. PubMed ID: 24176976 [TBL] [Abstract][Full Text] [Related]
19. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis. Magliozzi R; Fadda G; Brown RA; Bar-Or A; Howell OW; Hametner S; Marastoni D; Poli A; Nicholas R; Calabrese M; Monaco S; Reynolds R Ann Neurol; 2022 Oct; 92(4):670-685. PubMed ID: 35748636 [TBL] [Abstract][Full Text] [Related]